UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics

European psychiatry, 2010-06, Vol.25 (S2), p.S12-S21

Correll, C.U

2010

Volltextzugriff (PDF)

Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories

Psychological medicine, 2016-05, Vol.46 (7), p.1459-1472

2016

Volltextzugriff (PDF)

Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics

Molecular psychiatry, 2013-01, Vol.18 (1), p.53-66

2013

Volltextzugriff (PDF)

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

European psychiatry, 2011-04, Vol.26 (3), p.144-158

2011

Volltextzugriff (PDF)

Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables

Psychological medicine, 2014-07, Vol.44 (10), p.2017-2028

2014

Volltextzugriff (PDF)

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices

Psychological medicine, 2012-01, Vol.42 (1), p.125-147

2012

Volltextzugriff (PDF)

The Nucleolus: A Multiphase Condensate Balancing Ribosome Synthesis and Translational Capacity in Health, Aging and Ribosomopathies

Cells (Basel, Switzerland), 2019-08, Vol.8 (8), p.869

2019

Volltextzugriff (PDF)

Efficacy and tolerability of atypical antipsychotics: research trials and clinical reality

European neuropsychopharmacology, 2016-10, Vol.26, p.S764-S765

Correll, C

2016

Volltextzugriff (PDF)

Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management

Acta psychiatrica Scandinavica, 2015-08, Vol.132 (2), p.97-108

2015

Volltextzugriff (PDF)

Antipsychotic use and risk of life‐threatening medical events: umbrella review of observational studies

Acta psychiatrica Scandinavica, 2019-09, Vol.140 (3), p.227-243

2019

Volltextzugriff (PDF)

A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia

CNS drugs, 2022-07, Vol.36 (7), p.659-679

2022

Volltextzugriff (PDF)

C.06.04 Novel dopamine D2 partial agonists in the treatment of schizophrenia

European neuropsychopharmacology, 2015-09, Vol.25, p.S668-S668

Correll, C

2015

Volltextzugriff (PDF)

Inverse relationship between body mass index and mortality in older nursing home residents: a meta‐analysis of 19,538 elderly subjects

Obesity reviews, 2015-11, Vol.16 (11), p.1001-1015

2015

Volltextzugriff (PDF)

A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania

Psychological medicine, 2015-01, Vol.45 (2), p.299-317

2015

Volltextzugriff (PDF)

Pharmacotherapy of schizophrenia

Nervenarzt, 2020-01, Vol.91 (1), p.34-42

Correll, C U

2020

Volltextzugriff (PDF)

C.12.03 The role of LAI antipsychotics in the maintenance treatment of schizophrenia

European neuropsychopharmacology, 2014-10, Vol.24, p.S763-S763

Correll, C

2014

Volltextzugriff (PDF)

Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials

Schizophrenia bulletin, 2014-01, Vol.40 (1), p.192-213

2014

Volltextzugriff (PDF)

Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study

Psychological medicine, 2016-02, Vol.46 (3), p.623-635

2016

Volltextzugriff (PDF)

Utp14 Recruits and Activates the RNA Helicase Dhr1 To Undock U3 snoRNA from the Preribosome

Molecular and cellular biology, 2016-03, Vol.36 (6), p.965-978

2016

Volltextzugriff (PDF)

The DEAH-box helicase Dhr1 dissociates U3 from the pre-rRNA to promote formation of the central pseudoknot

PLoS biology, 2015-02, Vol.13 (2), p.e1002083-e1002083

2015

Volltextzugriff (PDF)

High resolution mapping and candidate gene identification of downy mildew race 16 resistance in spinach

BMC genomics, 2021-06, Vol.22 (1), p.1-478, Article 478

2021

Volltextzugriff (PDF)

A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia

Acta psychiatrica Scandinavica, 2014-12, Vol.130 (6), p.470-486

2014

Volltextzugriff (PDF)

Mapping and selection of downy mildew resistance in spinach cv. whale by low coverage whole genome sequencing

Frontiers in plant science, 2022-10, Vol.13, p.1012923

2022

Volltextzugriff (PDF)

C.04.03 Relevance of study design for the effectiveness of long-acting injectable antipsychotics in schizophrenia

European neuropsychopharmacology, 2013-10, Vol.23, p.S633-S634

Correll, C

2013

Volltextzugriff (PDF)

Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Pro

Nervenarzt, 2015-11, Vol.86 (11), p.1420-1423

2015

Volltextzugriff (PDF)

1 – 25 von 904

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(819)
Mit Volltextzugriff
(723)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(544)
Life Sciences & Biomedicine
(495)
Humans
(266)
Psychiatry
(212)
Biological And Medical Sciences
(140)
Male
(123)
Female
(114)
Plant Sciences
(103)
Schizophrenia
(97)
Adult
(86)
Fundamental And Applied Biological Sciences. Psychology
(82)
Adolescent
(65)
Animals
(62)
Medical Sciences
(61)
Middle Aged
(59)
Antipsychotics
(54)
Antipsychotic Agents - Therapeutic Use
(52)
Neurosciences & Neurology
(52)
Medicin Och Hälsovetenskap
(51)
Schizophrenia - Drug Therapy
(50)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plant Disease
(52)
Phytopathology
(46)
European Neuropsychopharmacology
(41)
European Psychiatry
(26)
Acta Psychiatrica Scandinavica
(24)
Schizophrenia Bulletin
(19)
Nervenarzt
(14)
Neuropsychiatric Disease And Treatment
(11)
Psychological Medicine
(11)
The Journal Of Clinical Psychiatry
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics

Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories

Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices

The Nucleolus: A Multiphase Condensate Balancing Ribosome Synthesis and Translational Capacity in Health, Aging and Ribosomopathies

Efficacy and tolerability of atypical antipsychotics: research trials and clinical reality

Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management

Antipsychotic use and risk of life‐threatening medical events: umbrella review of observational studies

A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia

C.06.04 Novel dopamine D2 partial agonists in the treatment of schizophrenia

Inverse relationship between body mass index and mortality in older nursing home residents: a meta‐analysis of 19,538 elderly subjects

A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania

Pharmacotherapy of schizophrenia

C.12.03 The role of LAI antipsychotics in the maintenance treatment of schizophrenia

Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials

Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study

Utp14 Recruits and Activates the RNA Helicase Dhr1 To Undock U3 snoRNA from the Preribosome

The DEAH-box helicase Dhr1 dissociates U3 from the pre-rRNA to promote formation of the central pseudoknot

High resolution mapping and candidate gene identification of downy mildew race 16 resistance in spinach

A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia

Mapping and selection of downy mildew resistance in spinach cv. whale by low coverage whole genome sequencing

C.04.03 Relevance of study design for the effectiveness of long-acting injectable antipsychotics in schizophrenia

Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Pro

Suchergebnisse filtern